SBRA logo

Sabra Health Care REIT, Inc. Stock Price

NasdaqGS:SBRA Community·US$5.6b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 17 Fair Values set on narratives written by author

SBRA Share Price Performance

US$22.36
4.38 (24.36%)
US$22.07
Fair Value
US$22.36
4.38 (24.36%)
1.3% overvalued intrinsic discount
US$22.07
Fair Value
Price US$22.36
AnalystConsensusTarget US$22.07

SBRA Community Narratives

·
Fair Value US$22.07 1.3% overvalued intrinsic discount

US Senior Living Demand Will Unlock Future Value

0users have liked this narrative
0users have commented on this narrative
8users have followed this narrative
US$22.07
1.3% overvalued intrinsic discount
Revenue
14.04% p.a.
Profit Margin
20.12%
Future PE
33.27x
Price in 2029
US$27.6

Trending Discussion

No trending discussion available.

Updated Narratives

SBRA logo

SBRA: Sector Repricing And Growing SHOP Exposure Will Shape Balanced 2026 Outlook

Fair Value: US$22.07 1.3% overvalued intrinsic discount
8 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Good value average dividend payer.

2 Risks
3 Rewards

Sabra Health Care REIT, Inc. Key Details

US$815.7m

Revenue

US$295.7m

Cost of Revenue

US$519.9m

Gross Profit

US$363.8m

Other Expenses

US$156.2m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 03, 2026
0.62
63.74%
19.15%
95.6%
View Full Analysis

About SBRA

Founded
2010
Employees
58
CEO
Richard Matros
WebsiteView website
www.sabrahealth.com

Sabra Health Care REIT, Inc. operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada. Sabra Health Care REIT, Inc. is incorporated on May 10th, 2010 and is based in Tustin, United States.

Recent SBRA News & Updates

Seeking Alpha Jul 09

Sabra Health Care: Pivoting To Win From An Unstoppable Demographic Tailwind

Summary Sabra Health Care REIT remains a Buy, driven by its aggressive pivot into the Seniors Housing Operating Portfolio model. SBRA's SHOP transition offers direct exposure to demographic tailwinds from the 'Silver Tsunami,' positioning for significant potential occupancy and AFFO growth. Q1 results were strong, with AFFO at $0.39/share, nearly reaching the annual investment target, and a 77% dividend payout ratio supporting a ~6% yield. Despite near-term macro headwinds and increased operational risk, SBRA's intrinsic value estimate of $23.41/share implies re-rating potential above current levels. Read the full article on Seeking Alpha

Recent updates

No updates